---
title: CRO Daily News — August 24, 2026
slug: daily-news-2026-08-24-cro
site: cro
post_kind: news
byline: BioBM
description: August 24 CRO daily: Novotech Opens Tokyo Office to Expand Japan Clinical Trial Operations; Novotech Opens Tokyo Office to Expand Clinical Services for…
canonical_url: https://www.cro.directory/posts/daily-news-2026-08-24-cro
published_at: 2026-08-24T23:59:18.258Z
last_updated: 2026-08-25T00:01:43.051Z
---

### [Novotech](/companies/novotech-cro) Opens Tokyo Office to Expand Japan Clinical Trial Operations
- [Novotech](/companies/novotech-cro), a global biotech CRO, opened a new Tokyo office to strengthen its Japan presence and support Japanese biopharma companies advancing clinical programs.
- The office serves as a strategic operations hub connecting sponsors across Asia-Pacific, the U.S., and Europe, leveraging Novotech's expertise in oncology, rare diseases, CNS, infectious diseases, immunology, and advanced therapies.

**Operational Impact**

[Novotech](/companies/novotech-cro)'s Tokyo hub reduces regional fragmentation for sponsors running cross-border trials, enabling Japanese biotech clients to access integrated clinical services across APAC, U.S., and European markets without managing multiple regional vendors.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/novotech-opens-tokyo-office-strengthening-japan-presence)*

---

### [Novotech](/companies/novotech-cro) Opens Tokyo Office to Expand Clinical Services for Japanese Biotech Sponsors
- Novotech inaugurated a Tokyo hub at Shinjuku i-Land Tower under Country Head Takeshi Mori, deepening clinical trial operations in Japan and strengthening support for Japanese biopharma sponsors entering global markets.
- The office integrates Novotech's Asia-Pacific network (30+ offices, 7,000+ trial sites) with early-phase development in Australia, FDA-aligned protocol support, and U.S. scientific expertise to enable cross-border trial management without multiple regional vendors.
- The expansion positions Novotech to serve Japan's growing biotech sector as emerging and mid-size companies seek to advance programs toward FDA, EMA, and PMDA regulatory submissions.

**Operational Impact**

Japanese biopharma sponsors can now access [Novotech](/companies/novotech-cro)'s integrated clinical development platform—including early-phase capabilities in Australia and FDA-aligned protocol support—through a dedicated Tokyo hub, reducing the need to engage multiple regional CRO partners for cross-border trials.

*Source: [PharmaSource RSS](https://pharmasource.global/content/novotech-opens-tokyo-cro-office-to-support-japanese-biopharma-sponsors-advancing-into-global-markets)*

---

### Emmes Group Appoints Rama Kondru as CEO; Prioritizes AI and Clinical Technology Integration
- Dr. Rama Kondru, former Co-CEO of [Medidata Solutions](/companies/medidata-solutions), assumes CEO role at Emmes Group, bringing 25 years of pharma, healthcare tech, and data science experience.
- Kondru led [Veridix](/companies/veridix), Emmes' AI and data sciences subsidiary, and plans to combine AI, technology, and clinical expertise to accelerate trial design and execution.

**Operational Impact**

Emmes' appointment of a technology-platform scaling executive as CEO may accelerate adoption of AI and cloud-based trial infrastructure across the CRO's customer base, potentially reshaping competitive positioning in digital clinical development.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/the-emmes-group-names-rama-kondru-ceo)*

## References

1. [Contract Pharma Breaking News RSS — Novotech Opens Tokyo Office to Expand Japan Clinical Trial Operations](https://www.contractpharma.com/breaking-news/novotech-opens-tokyo-office-strengthening-japan-presence)
2. [PharmaSource RSS — Novotech Opens Tokyo Office to Expand Clinical Services for Japanese Biotech Sponsors](https://pharmasource.global/content/novotech-opens-tokyo-cro-office-to-support-japanese-biopharma-sponsors-advancing-into-global-markets)
3. [Contract Pharma Breaking News RSS — Emmes Group Appoints Rama Kondru as CEO; Prioritizes AI and Clinical Technology Inte](https://www.contractpharma.com/breaking-news/the-emmes-group-names-rama-kondru-ceo)

Source: https://www.cro.directory/posts/daily-news-2026-08-24-cro